Target
Arginase-2, mitochondrial
Ligand
BDBM50561038
Substrate
n/a
Meas. Tech.
Biological Activity of Examples 1 to 30
IC50
20.0±n/a nM
Citation
 Mlynarski, SNGrebe, TKawatkar, SFinlay, MRSimpson, IWang, JCook, SWu, D Arginase inhibitors and methods of use thereof US Patent  US11420984 Publication Date 8/23/2022 
Target
Name:
Arginase-2, mitochondrial
Synonyms:
ARG2 | ARGI2_HUMAN | Arginase II | Kidney-type arginase | Non-hepatic arginase | Type II arginase
Type:
PROTEIN
Mol. Mass.:
38576.93
Organism:
Homo sapiens (Human)
Description:
ChEMBL_978892
Residue:
354
Sequence:
MSLRGSLSRLLQTRVHSILKKSVHSVAVIGAPFSQGQKRKGVEHGPAAIREAGLMKRLSSLGCHLKDFGDLSFTPVPKDDLYNNLIVNPRSVGLANQELAEVVSRAVSDGYSCVTLGGDHSLAIGTISGHARHCPDLCVVWVDAHADINTPLTTSSGNLHGQPVSFLLRELQDKVPQLPGFSWIKPCISSASIVYIGLRDVDPPEHFILKNYDIQYFSMRDIDRLGIQKVMERTFDLLIGKRQRPIHLSFDIDAFDPTLAPATGTPVVGGLTYREGMYIAEEIHNTGLLSALDLVEVNPQLATSEEEAKTTANLAVDVIASSFGQTREGGHIVYDQLPTPSSPDESENQARVRI
  
Inhibitor
Name:
BDBM50561038
Synonyms:
CHEMBL4752307 | US11420984, Example 7
Type:
Small organic molecule
Emp. Form.:
C9H19BN2O4
Mol. Mass.:
230.069
SMILES:
N[C@H]1CN[C@](CCCCB(O)O)(C1)C(O)=O |r|
Structure:
Search PDB for entries with ligand similarity: